98
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Prevention and Treatment of Carbapenem-Resistant Organism Bacilli from Liver Transplantation Donors – Single Center Experience

, , , , , & show all
Pages 47-52 | Published online: 06 Jan 2022

References

  • Hilmi IA, Al-Khafaji A, Damian D, Rosario-Rivera BL, Abdullah A, Kellum JA. Liberation from renal replacement therapy after cadaveric liver transplantation. Transplant Direct. 2016;2(11):e110. doi:10.1097/TXD.0000000000000622
  • Togashi J, Akamastu N, Kokudo N. Living donor liver transplantation for hepatocellular carcinoma at the University of Tokyo Hospital. Hepatobiliary Surg Nutr. 2016;5(5):399–407. doi:10.21037/hbsn.2016.08.05
  • Kaido T, Mori A, Ogura Y, et al. Pre- and perioperative factors affecting infection after living donor liver transplantation. Nutrition. 2012;28(11–12):1104–1108. doi:10.1016/j.nut.2012.02.007
  • Kim SI. Bacterial infection after liver transplantation. World J Gastroenterol. 2014;20(20):6211–6220. doi:10.3748/wjg.v20.i20.6211
  • Lin DD, Liu JN. Management of perioperative infection in liver transplantation. Beijing Med. 2017;39(9):895–896.
  • Lübbert C, Becker-Rux D, Rodloff AC, et al. Colonization of liver transplant recipients with KPC-producing Klebsiella pneumoniae is associated with high infection rates and excess mortality: a case-control analysis. Infection. 2014;42(2):309–316. doi:10.1007/s15010-013-0547-3
  • Satlin MJ, Jenkins SG, Walsh TJ. The global challenge of carbapenem-resistant Enterobacteriaceae in transplant recipients and patients with hematologic malignancies. Clin Infect Dis. 2014;58(9):1274–1283. doi:10.1093/cid/ciu052
  • Logan LK, Weinstein RA. The epidemiology of carbapenem-resistant Enterobacteriaceae: the impact and evolution of a global menace. J Infect Dis. 2017;215(suppl_1):S28–S36. doi:10.1093/infdis/jiw282
  • Tacconelli E, Carrara E, Savoldi A, et al.; WHO Pathogens Priority List Working Group. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018;18(3):318–327. doi:10.1016/S1473-3099(17)30753-3
  • Taminato M, Fram D, Pereira RRF, et al. Infection related to Klebsiella pneumoniae producing carbapenemase in renal transplant patients. Rev Bras Enferm. 2019;72(3):760–766. doi:10.1590/0034-7167-2019-0009
  • Moore NM, Cantón R, Carretto E, Peterson LR, Sautter RL, Traczewski MM; Carba-R Study Team. Rapid Identification of Five Classes of Carbapenem Resistance Genes Directly from Rectal Swabs by Use of the Xpert Carba-R Assay. J Clin Microbiol. 2017;55(7):2268–2275. doi:10.1128/JCM.00137-17
  • Zhang Y, Jin L, Ouyang P, et al.; China Carbapenem-Resistant Enterobacteriaceae (CRE) Network. Evolution of hypervirulence in carbapenem-resistant Klebsiella pneumoniae in China: a multicentre, molecular epidemiological analysis. J Antimicrob Chemother. 2020;75(2):327–336. doi:10.1093/jac/dkz446
  • World Health Organization. Guidelines for the Prevention and Control of Carbapenem-Resistant Enterobacteriaceae, Acinetobacter Baumannii and Pseudomonas Aeruginosa in Health Care Facilities. Geneva: World Health Organization; 2017.
  • Gorrie CL, Mirceta M, Wick RR, et al. Gastrointestinal carriage is a major reservoir of Klebsiella pneumoniae infection in intensive care patients. Clin Infect Dis. 2017;65(2):208–215. doi:10.1093/cid/cix270